SCHEMBL7430647

SCHEMBL7430647

O=C(Cl)NN1CCCCCC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.45
LIPE Q05469 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
ALOX12 P18054 1/20 0.37
NFKB1 P19838 1/20 0.37
CNR1 P21554 2/20 0.36
CNR2 P34972 2/20 0.35
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2891503 1.00 HTT (0.45) HTTLIPEL3MBTL1LMNAPOLB
SCHEMBL364908 0.97
SCHEMBL5010340 0.80 L3MBTL3 (0.45) L3MBTL1ALDH1A1KDM4ECYP3A4
Hydrochloric Acid SCHEMBL6202425 0.78 L3MBTL3 (0.44) L3MBTL1ALDH1A1KDM4ECYP3A4
SCHEMBL21798768 0.78 HTT (0.48) HTTLIPEL3MBTL1LMNAPOLB
SCHEMBL28385713 0.77 CA12 (0.35) HTT
SCHEMBL34638 0.76 HTT (0.52) HTTLIPEL3MBTL1LMNAPOLB
SCHEMBL3158910 0.76 HTT (0.47) HTTLIPEL3MBTL1LMNAPOLB
SCHEMBL9727085 0.76 HTT (0.52) HTTLIPEL3MBTL1LMNAPOLB
SCHEMBL365772 0.75 EPHX2 (0.53) HTTLIPEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362174-B1 ANALGESICS, ANTIISCHEMIC AGENTS, ANTIEOILEPTIC AGENTS WARNER-LAMBERT COMPANY 2002-03-26 US disclosed
US-20020028801-A1 Reduced dipeptide analogues as calcium channel antagonitsts RAFFERTY MICHAEL FRANCIS (US) 2002-03-07 US disclosed
US-6316440-B1 TREATMENT OF STROKE, HEAD TRAUMA, CEREBRAL ISCHEMIA, PAIN AND EPILEPSY WARNER-LAMBERT COMPANY 2001-11-13 US disclosed
WO-2000006559-A1 REDUCED DIPEPTIDE ANALOGUES AS CALCIUM CHANNEL ANTAGONISTS WARNER-LAMBERT COMPANY (US) 2000-02-10 WO disclosed
EP-0220034-B1 MALONATE DERIVATIVES USEFUL AS LIGHT STABILIZERS FOR PLASTICS ICI AMERICAS INC. (US) 1992-06-24 EP disclosed
EP-0219332-B1 TARTRATE COMPOUNDS USEFUL AS LIGHT STABILIZERS FOR PLASTICS ICI AMERICAS INC. (US) 1992-04-29 EP disclosed
US-4851461-A PHOTOSTABILIZERS ICI AMERICAS INC. (US) 1989-07-25 US disclosed
US-4804699-A Monomeric and oligomeric glutarate-based light stabilizers for plastics ICI AMERICAS INC. (US) 1989-02-14 US disclosed
EP-0291238-A2 Monomeric and oligomeric glutarate-based light stabilisers for plastics ICI AMERICAS INC. (US) 1988-11-17 EP disclosed
US-4710527-A STERICALLY HINDERED SPIROACETALS OF POLYALKYLPIPERIDIN-4-ONES ICI AMERICAS INC. (US) 1987-12-01 US disclosed
US-4701485-A Malonate-based light stabilizers for plastics ICI AMERICAS INC. (US) 1987-10-20 US disclosed
US-4690963-A POLYALKYL-1,4-DIOXA-8-AZASPIRO(4.5)DECANE-2,3-DICARBOXYLIC ACIDS, ESTERS OR AMIDES; POLYPROPYLENE FILMS ICI AMERICAS INC. (US) 1987-09-01 US disclosed
US-4689360-A SPIRO RING CONTAINING ESTERS ICI AMERICAS INC. (US) 1987-08-25 US disclosed
US-4687800-A POLYALKYL PIPERIDIN-4-YL CONTAINING ACETAL ESTERS AND AMIDES ICI AMERICAS INC. (US) 1987-08-18 US disclosed
EP-0222512-A2 Malonate compounds useful as light stabilizers for plastics CYTEC TECHNOLOGY CORP. (US) 1987-05-20 EP disclosed
EP-0220034-A2 Malonate derivatives useful as light stabilizers for plastics ICI AMERICAS INC. (US) 1987-04-29 EP disclosed
EP-0219332-A2 Tartrate compounds useful as light stabilizers for plastics ICI AMERICAS INC. (US) 1987-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028801-A1 Reduced dipeptide analogues as calcium channel antagonitsts CACNA1E, RYR1, CACNA1B HTT 1142/4885LIPE 4607/4885L3MBTL1 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.